These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32034075)

  • 1.
    Sato N; Stringaris K; Davidson-Moncada JK; Reger R; Adler SS; Dunbar C; Choyke PL; Childs RW
    Clin Cancer Res; 2020 Jun; 26(11):2573-2581. PubMed ID: 32034075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies.
    Sato N; Wu H; Asiedu KO; Szajek LP; Griffiths GL; Choyke PL
    Radiology; 2015 May; 275(2):490-500. PubMed ID: 25706654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracking of NK Cells by Positron Emission Tomography Using
    Sato N; Szajek LP; Choyke PL
    Methods Mol Biol; 2022; 2463():153-161. PubMed ID: 35344173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Marrow Cell Trafficking Analyzed by
    Asiedu KO; Koyasu S; Szajek LP; Choyke PL; Sato N
    Clin Cancer Res; 2017 Jun; 23(11):2759-2768. PubMed ID: 27965305
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging of cell-based therapy using
    Kurebayashi Y; Choyke PL; Sato N
    Nanotheranostics; 2021; 5(1):27-35. PubMed ID: 33391973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo PET Imaging of
    Pham TT; Chenoweth A; Patel N; Banu A; Osborn G; Blower PJ; Karagiannis SN; Ma MT
    J Nucl Med; 2024 Jul; 65(7):1035-1042. PubMed ID: 38844362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A kit formulation for the preparation of [
    Man F; Khan AA; Carrascal-Miniño A; Blower PJ; T M de Rosales R
    Nucl Med Biol; 2020; 90-91():31-40. PubMed ID: 32979725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with
    Weist MR; Starr R; Aguilar B; Chea J; Miles JK; Poku E; Gerdts E; Yang X; Priceman SJ; Forman SJ; Colcher D; Brown CE; Shively JE
    J Nucl Med; 2018 Oct; 59(10):1531-1537. PubMed ID: 29728514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of chimeric antigen receptor modified T cells expressing scFv-IL-13Rα2 after radiolabeling with
    Leland P; Kumar D; Nimmagadda S; Bauer SR; Puri RK; Joshi BH
    J Transl Med; 2023 Jun; 21(1):367. PubMed ID: 37286997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility study of
    Wang XY; Wang Y; Wu Q; Liu JJ; Liu Y; Pan DH; Qi W; Wang LZ; Yan JJ; Xu YP; Wang GJ; Miao LY; Yu L; Yang M
    Acta Pharmacol Sin; 2021 May; 42(5):824-831. PubMed ID: 32901086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and (111)In-Oxine Labeling of Murine NK Cells for Assessment of Cell Trafficking in Orthotopic Lung Tumor Model.
    Malviya G; Nayak T; Gerdes C; Dierckx RA; Signore A; de Vries EF
    Mol Pharm; 2016 Apr; 13(4):1329-38. PubMed ID: 26962716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Bone Marrow Homing of Natural Killer Cells Following mRNA Transfection With Gain-of-Function Variant CXCR4
    Levy E; Reger R; Segerberg F; Lambert M; Leijonhufvud C; Baumer Y; Carlsten M; Childs R
    Front Immunol; 2019; 10():1262. PubMed ID: 31231387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatio-temporal biodistribution of
    Sta Maria NS; Khawli LA; Pachipulusu V; Lin SW; Zheng L; Cohrs D; Liu X; Hu P; Epstein AL; Jacobs RE
    Sci Rep; 2021 Jul; 11(1):15077. PubMed ID: 34302002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    England CG; Ehlerding EB; Hernandez R; Rekoske BT; Graves SA; Sun H; Liu G; McNeel DG; Barnhart TE; Cai W
    J Nucl Med; 2017 Jan; 58(1):162-168. PubMed ID: 27493273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimisation of the Synthesis and Cell Labelling Conditions for [
    Friberger I; Jussing E; Han J; Goos JACM; Siikanen J; Kaipe H; Lambert M; Harris RA; Samén E; Carlsten M; Holmin S; Tran TA
    Mol Imaging Biol; 2021 Dec; 23(6):952-962. PubMed ID: 34231103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Time Tracking of
    Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
    Front Immunol; 2018; 9():825. PubMed ID: 29770131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution of 89Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography imaging in Sprague-Dawley rats.
    Wang S; Wang Y; Xu B; Qin T; Lv Y; Yan H; Shao Y; Fang Y; Zheng S; Qiu Y
    Nucl Med Commun; 2022 Jul; 43(7):834-846. PubMed ID: 35438673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.
    Rizvi SN; Visser OJ; Vosjan MJ; van Lingen A; Hoekstra OS; Zijlstra JM; Huijgens PC; van Dongen GA; Lubberink M
    Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):512-20. PubMed ID: 22218876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow cell homing to sites of acute tibial fracture:
    Asiedu KO; Ferdousi M; Ton PT; Adler SS; Choyke PL; Sato N
    EJNMMI Res; 2018 Dec; 8(1):109. PubMed ID: 30547233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
    Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.